In vivo activity of gemcitabine-loaded PEGylated small unilamellar liposomes against pancreatic cancer

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.64, Iss.5, 2009-10, pp. : 1009-1020

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Erlotinib or capecitabine with gemcitabine in pancreatic cancer?

By de Jager Jenny Stebbing Justin

Future Oncology, Vol. 2, Iss. 2, 2006-04 ,pp. : 161-163

Future Medicine

Access to resources Recommend Favorite

Pancreatic cancer – cost for overtreatment with gemcitabine

By Ansari Daniel Tingstedt Bobby Andersson Roland

Acta Oncologica, Vol. 52, Iss. 6, 2013-08 ,pp. : 1146-1151

Informa Healthcare

Access to resources Recommend Favorite

Emodin potentiates the antitumor effects of gemcitabine in PANC-1 pancreatic cancer xenograft model in vivo via inhibition of inhibitors of apoptosis

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 1849-1857

Spandidos Publications

Access to resources Recommend Favorite

Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway

Molecular Medicine Reports, Vol. 10, Iss. 6, 2014-01 ,pp. : 3027-3034

Spandidos Publications

Access to resources Recommend Favorite

Oridonin enhances antitumor activity of gemcitabine in pancreatic cancer through MAPK-p38 signaling pathway

International Journal of Oncology, Vol. 41, Iss. 3, 2012-01 ,pp. : 949-958

Spandidos Publications

Access to resources Recommend Favorite